• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视尼古丁减少策略:科学与未来方向。

Nicotine reduction revisited: science and future directions.

机构信息

Tobacco Use Research Center, University of Minnesota, 717 Delaware St SE, Minneapolis, Minnesota 55414, USA.

出版信息

Tob Control. 2010 Oct;19(5):e1-10. doi: 10.1136/tc.2009.035584.

DOI:10.1136/tc.2009.035584
PMID:20876072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4618689/
Abstract

Regulation of nicotine levels in cigarettes and other tobacco products is now possible with the passage of the Family Smoking Prevention and Tobacco Control Act (FSPTCA) in 2009, giving the US Food and Drug Administration (FDA) authority to regulate tobacco products, and with Articles 9-11 of the WHO Framework Convention on Tobacco Control. Both regulatory approaches allow establishing product standards for tobacco constituents, including nicotine. The FSPTCA does not allow nicotine levels to be decreased to zero, although the FDA has the authority to reduce nicotine yields to very low, presumably non-addicting levels. The proposal to reduce levels of nicotine to a level that is non-addicting was originally suggested in 1994. Reduction of nicotine in tobacco products could potentially have a profound impact on reducing tobacco-related morbidity and mortality. To examine this issue, two meetings were convened in the US with non-tobacco-industry scientists of varied disciplines, tobacco control policymakers and representatives of government agencies. This article provides an overview of the current science in the area of reduced nicotine content cigarettes and key conclusions and recommendations for research and policy that emerged from the deliberations of the meeting members.

摘要

《家庭吸烟预防及烟草控制法案》(Family Smoking Prevention and Tobacco Control Act,FSPTCA)于 2009 年通过,使美国食品和药物管理局(Food and Drug Administration,FDA)有权监管烟草产品,这标志着通过立法来调节香烟及其他烟草制品中的尼古丁含量成为可能。此外,世界卫生组织《烟草控制框架公约》第 9-11 条也对此加以规定。这两种监管途径都允许制定烟草成分(包括尼古丁)的产品标准。《家庭吸烟预防及烟草控制法案》不允许将尼古丁含量降低至零,但 FDA 有权将尼古丁的释放量降低到非常低的水平,据推测,这种水平是不会让人上瘾的。将尼古丁水平降低到非成瘾水平的提议最初是在 1994 年提出的。降低烟草制品中的尼古丁含量可能会对降低与烟草相关的发病率和死亡率产生深远影响。为了研究这个问题,在美国召集了两次会议,与会者是非烟草行业的具有不同学科背景的科学家、烟草控制政策制定者以及政府机构的代表。本文概述了降低尼古丁含量香烟领域的当前科学,并提供了会议成员审议后得出的关键结论和研究与政策建议。

相似文献

1
Nicotine reduction revisited: science and future directions.重新审视尼古丁减少策略:科学与未来方向。
Tob Control. 2010 Oct;19(5):e1-10. doi: 10.1136/tc.2009.035584.
2
No sisyphean task: how the FDA can regulate electronic cigarettes.并非徒劳无功的任务:美国食品药品监督管理局如何监管电子烟
Yale J Health Policy Law Ethics. 2013 Summer;13(2):326-74.
3
Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.尼古丁削减策略:科学现状以及对烟草控制政策和 FDA 烟草制品监管的挑战。
Prev Med. 2018 Dec;117:5-7. doi: 10.1016/j.ypmed.2018.06.012. Epub 2018 Jun 23.
4
Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.可燃烟草的降低尼古丁产品标准:建立有效监管的实证基础。
Prev Med. 2014 Nov;68:17-22. doi: 10.1016/j.ypmed.2014.06.020. Epub 2014 Jun 23.
5
Impact of tobacco regulation on animal research: new perspectives and opportunities.烟草监管对动物研究的影响:新视角与新机遇。
Nicotine Tob Res. 2012 Nov;14(11):1319-38. doi: 10.1093/ntr/nts162. Epub 2012 Sep 4.
6
Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act.与《家庭吸烟预防和烟草控制法》下的烟草产品标准制定相关的研究机会。
Nicotine Tob Res. 2012 Jan;14(1):18-28. doi: 10.1093/ntr/ntq216. Epub 2011 Jan 10.
7
Reducing the nicotine content to make cigarettes less addictive.降低尼古丁含量,使香烟的成瘾性降低。
Tob Control. 2013 May;22 Suppl 1(Suppl 1):i14-7. doi: 10.1136/tobaccocontrol-2012-050860.
8
Anticipating Industry Arguments: The US Food and Drug Administration's Authority to Reduce Nicotine Levels in Cigarettes.预期行业论点:美国食品和药物管理局降低香烟尼古丁含量的权力。
Public Health Rep. 2018 Jul/Aug;133(4):502-506. doi: 10.1177/0033354918776935. Epub 2018 Jun 7.
9
Permissive nicotine regulation as a complement to traditional tobacco control.宽容性尼古丁监管作为传统烟草控制的补充措施。
BMC Public Health. 2005 Feb 24;5:18. doi: 10.1186/1471-2458-5-18.
10
Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward.尼古丁精神药理学研究对美国及全球烟草监管的贡献:回顾与展望
Psychopharmacology (Berl). 2006 Mar;184(3-4):286-91. doi: 10.1007/s00213-006-0308-4. Epub 2006 Feb 4.

引用本文的文献

1
Perceptions of the Addictiveness of Low-Nicotine Cigarettes Versus Typical Cigarettes and Exposure to Tobacco Industry-Sponsored Corrective Campaign.对低尼古丁香烟与普通香烟成瘾性的认知差异,以及对烟草业赞助的纠正性宣传活动的接触。
Subst Use Misuse. 2024;59(10):1511-1518. doi: 10.1080/10826084.2024.2360100. Epub 2024 Jun 3.
2
"I think we can do without [tobacco]": support for policies to end the tobacco epidemic among California adolescents.“我认为我们可以摆脱(烟草)”:对加利福尼亚州青少年中终结烟草流行政策的支持。
Tob Control. 2023 Dec 26. doi: 10.1136/tc-2023-058288.
3
The Development and Testing of a Point-of-Sale E-Cigarette Health Communication Campaign.销售点电子烟健康传播活动的开发和测试。
Health Commun. 2024 Oct;39(11):2307-2318. doi: 10.1080/10410236.2023.2265648. Epub 2023 Nov 8.
4
Practical guidance on modeling choices for the virtual twins method.虚拟双胞胎方法建模选择的实用指南。
J Biopharm Stat. 2023 Sep 3;33(5):653-676. doi: 10.1080/10543406.2023.2170404. Epub 2023 Mar 6.
5
The Effects of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Smoking Behavior: An Ecological Momentary Assessment Study.香烟尼古丁含量立即降低与逐渐降低对吸烟行为的影响:一项生态瞬时评估研究。
Front Psychiatry. 2022 May 11;13:884605. doi: 10.3389/fpsyt.2022.884605. eCollection 2022.
6
Responses to reduced nicotine cigarette marketing features: a systematic review.对低尼古丁香烟营销特点的反应:一项系统综述
Tob Control. 2021 Oct 7. doi: 10.1136/tobaccocontrol-2021-056826.
7
A review of the evidence on cigarettes with reduced addictiveness potential.降低成瘾潜力香烟的证据综述。
Int J Drug Policy. 2022 Jan;99:103436. doi: 10.1016/j.drugpo.2021.103436. Epub 2021 Sep 15.
8
Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers With Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial.经济社会地位较低的吸烟者改用尼古丁含量逐渐降低的香烟:一项双盲随机临床试验。
Nicotine Tob Res. 2021 May 24;23(6):992-1001. doi: 10.1093/ntr/ntaa247.
9
An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and Outcomes.评估尼古丁产品标准的潜在意外后果:关注饮酒史和结果。
Nicotine Tob Res. 2021 Jun 8;23(7):1168-1175. doi: 10.1093/ntr/ntaa236.
10
Acute nicotine reinforcement requires ability to discriminate the stimulus effects of nicotine.急性尼古丁强化需要有辨别尼古丁刺激效应的能力。
Exp Clin Psychopharmacol. 2022 Jun;30(3):253-268. doi: 10.1037/pha0000433. Epub 2020 Oct 29.

本文引用的文献

1
Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule.限制香烟和无烟烟草销售与分销以保护儿童和青少年的规定。最终规则。
Fed Regist. 2010 Mar 19;75(53):13225-32.
2
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.低尼古丁含量香烟:对毒物暴露、依赖和戒烟的影响。
Addiction. 2010 Feb;105(2):343-55. doi: 10.1111/j.1360-0443.2009.02780.x.
3
Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats.性别和卵巢激素会影响大鼠青春期对尼古丁的易感性和动机。
Pharmacol Biochem Behav. 2009 Nov;94(1):43-50. doi: 10.1016/j.pbb.2009.07.004. Epub 2009 Jul 18.
4
Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.长期接触去尼古丁香烟,无论是否有经皮尼古丁。
Drug Alcohol Depend. 2009 Sep 1;104(1-2):23-33. doi: 10.1016/j.drugalcdep.2009.01.021. Epub 2009 May 15.
5
The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats.五种微量烟草生物碱的添加增加了尼古丁诱导的大鼠过度活跃、敏化和静脉内自我给药。
Int J Neuropsychopharmacol. 2009 Nov;12(10):1355-66. doi: 10.1017/S1461145709000273. Epub 2009 Apr 15.
6
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.烟草依赖与戒断:药物治疗的科学依据、挑战与机遇
Pharmacol Ther. 2009 Jul;123(1):1-16. doi: 10.1016/j.pharmthera.2009.03.011. Epub 2009 Apr 8.
7
Progressive commercial cigarette yield reduction: biochemical exposure and behavioral assessment.商业卷烟产量逐步降低:生化暴露与行为评估
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):876-83. doi: 10.1158/1055-9965.EPI-08-0731. Epub 2009 Mar 3.
8
Linking quantity and frequency profiles of cigarette smoking to the presence of nicotine dependence symptoms among adolescent smokers: findings from the 2004 National Youth Tobacco Survey.将青少年吸烟者的吸烟量和吸烟频率特征与尼古丁依赖症状的存在相联系:2004年全国青少年烟草调查结果
Nicotine Tob Res. 2009 Jan;11(1):49-57. doi: 10.1093/ntr/ntn008. Epub 2009 Jan 27.
9
Approaches, challenges, and experience in assessing free nicotine.评估游离尼古丁的方法、挑战及经验
Handb Exp Pharmacol. 2009(192):437-56. doi: 10.1007/978-3-540-69248-5_15.
10
Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans?尼古丁奖赏的啮齿动物模型:它们能告诉我们关于人类烟草滥用的哪些信息?
Pharmacol Biochem Behav. 2009 Feb;91(4):481-8. doi: 10.1016/j.pbb.2008.12.011. Epub 2008 Dec 24.